Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease.
Freedman
Barry I
BI
Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1053, USA. bfreedma @ wfubmc.edu
Shihabi
Zak K
ZK
Andries
Lilian
L
Cardona
Cesar Y
CY
Peacock
Todd P
TP
Byers
Joyce R
JR
Russell
Gregory B
GB
Stratta
Robert J
RJ
Bleyer
Anthony J
AJ
D000368:Aged; D048909:Diabetes Complications / Q000097:blood*; D003920:Diabetes Mellitus / Q000097:blood*; D005260:Female; D005919:Glomerular Filtration Rate; D006442:Glycated Hemoglobin / Q000096:biosynthesis*; D017127:Glycation End Products, Advanced; D006801:Humans; D006943:Hyperglycemia / Q000097:blood* / Q000150:complications*; D007004:Hypoglycemic Agents; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000150:complications*; D016030:Kidney Transplantation / Q000379:methods; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D012709:Serum Albumin / Q000096:biosynthesis*; D000093423:Glycated Serum Albumin
D006442:Glycated Hemoglobin; D017127:Glycation End Products, Advanced; D007004:Hypoglycemic Agents; D012709:Serum Albumin; D000093423:Glycated Serum Albumin; C517652:hemoglobin A1c protein, human